Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine for Refractory Chronic Migraine: a Pilot Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03896256

Organisation Name: Thomas Jefferson University

Overal Status: Completed

Start Date: March 22, 2019

Last Update: March 11, 2020

Lead Sponsor: Thomas Jefferson University

Brief Summary: Ketamine is a drug used for anesthesia but at low doses it is a very effective pain reliever in several chronic conditions. Preliminary studies have shown that ketamine might be effective for patients with refractory chronic migraine, which is a severe type of headache for which patients usually have tried and failed many medications and can cause severe disability to their lives. This study will evaluate ketamine prospectively when given to patients who have "failed" an initial inpatient treatment.

Conditions:
  • Migraine Headache With Intractable Migraine


Total execution time in seconds: 1.3353669643402